Gastrointestinal activity following bone marrow scintigraphy with technetium-99m nanocolloid in patients with multiple myeloma.
Unexpected abdominal activity was registered later than 1 h post injection in technetium-99m bone marrow scintigrams of 13 multiple myeloma patients and of five controls. The activity was considered to be localised in the gastro-intestinal tract. It is attributed to accumulation of degradation products of the used nanocolloid tracer. Corresponding results are known in patients with inflammatory bowel disease when scintigraphy is performed with other radiopharmaceuticals.
Agren
B
B
Department of Diagnostic Radiology, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
Måre
K
K
Aspelin
P
P
D000328:Adult; D001853:Bone Marrow / Q000000981:diagnostic imaging*; D004064:Digestive System / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013668:Technetium Tc 99m Aggregated Albumin; D013961:Thyroid Gland / Q000000981:diagnostic imaging
D013668:Technetium Tc 99m Aggregated Albumin; C083602:technetium Tc 99m nanocolloid